# Apimeds Pharmaceuticals US Inc. (APUS)

Source: https://www.quantisnow.com/company/APUS
Generated: 2026-11-09T21:35:36.986Z

- Ticker: APUS
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2025
- SEC CIK: 0001894525

## Latest APUS news and filings

- 2026-11-09 13:00 UTC [MindWave Innovations Inc. USA and Skalup Capital Singapore Form Bermuda Insurance Joint Venture, Pursue Insurance License with Bermuda Monetary Authority](https://www.quantisnow.com/insight/mindwave-innovations-inc-usa-and-skalup-capital-singapore-form-bermuda-6780308)
- 2026-11-05 19:58 UTC [SEC Form 3] [SEC Form 3 filed by new insider Chae Sungjoon](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-chae-sungjoon-6775778)
- 2026-11-03 13:00 UTC [IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.](https://www.quantisnow.com/insight/ibn-announces-cryptocurrencywire-audio-production-featuring-dr-vin-menon-ceo-6768453)
- 2026-11-02 17:09 UTC [SEC Form 3] [SEC Form 3 filed by new insider Sherb Eric Michael](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-sherb-eric-michael-6766691)
- 2026-11-02 16:59 UTC [SEC Form 3] [SEC Form 3 filed by new insider Menon Vin](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-menon-vin-6766681)
- 2026-10-13 13:43 UTC [NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide](https://www.quantisnow.com/insight/nila-token-to-begin-trading-on-pionex-opening-access-to-6744630)
- 2026-10-13 13:10 UTC [SEC Form 8-K] [SEC Form 8-K filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-apimeds-pharmaceuticals-us-inc-6744586)
- 2026-10-09 22:00 UTC [MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure](https://www.quantisnow.com/insight/mindwave-innovations-signs-3-client-network-agreements-in-10-days-6743286)
- 2026-10-05 12:00 UTC [MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network](https://www.quantisnow.com/insight/mindwave-innovations-signs-agreement-with-us-based-blockassure-to-build-and-6735953)
- 2026-10-01 13:15 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-leadership-update-6731806)
- 2026-09-29 20:15 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-other-events-6729290)
- 2026-09-29 12:30 UTC [MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media](https://www.quantisnow.com/insight/mindwave-innovations-expands-us-commercial-footprint-with-second-agreement-to-6728654)
- 2026-09-24 12:30 UTC [MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits](https://www.quantisnow.com/insight/mindwave-innovations-signs-agreement-to-build-and-operate-aquaechain-a-6724922)
- 2026-09-23 00:18 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-material-modification-6723480)
- 2026-09-18 18:00 UTC [IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.](https://www.quantisnow.com/insight/ibn-initiates-coverage-of-apimeds-pharmaceuticals-us-inc-6720360)
- 2026-09-11 13:10 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-entry-into-6712620)
- 2026-08-21 21:12 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-entry-into-6691683)
- 2026-08-14 20:22 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-apimeds-pharmaceuticals-us-inc-6683122)
- 2026-08-06 21:25 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-other-events-6670071)
- 2026-08-03 13:00 UTC [NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange](https://www.quantisnow.com/insight/nila-token-now-available-to-eligible-us-users-on-webot-6658996)
- 2026-07-28 12:30 UTC [MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October](https://www.quantisnow.com/insight/mindwave-innovations-inc-a-wholly-owned-subsidiary-of-apimeds-pharmaceuticals-6650819)
- 2026-07-13 20:30 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-other-events-6635524)
- 2026-05-26 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-apimeds-pharmaceuticals-us-inc-6572118)
- 2026-05-15 20:05 UTC [SEC Form NT 10-Q filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-apimeds-pharmaceuticals-us-inc-6557133)
- 2026-05-05 18:07 UTC [Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-settles-with-inscobee-merger-proceeds-100-million-6531544)
- 2026-05-05 16:30 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-leadership-update-6531428)
- 2026-05-04 10:57 UTC [SEC Form 10-K] [SEC Form 10-K filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-apimeds-pharmaceuticals-us-inc-6527863)
- 2026-05-04 10:15 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-entry-into-6527827)
- 2026-04-22 21:06 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-notice-of-6510891)
- 2026-04-16 20:30 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-other-events-6503396)
- 2026-04-09 20:36 UTC [SEC Form 425] [SEC Form 425 filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-apimeds-pharmaceuticals-us-inc-6495024)
- 2026-04-09 20:30 UTC [SEC Form 8-K] [Amendment: Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-leadership-6494961)
- 2026-03-31 20:57 UTC [SEC Form NT 10-K filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-apimeds-pharmaceuticals-us-inc-6479796)
- 2026-03-26 20:46 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-leadership-update-6471616)
- 2026-03-25 11:00 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Leadership Update, Other Events, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-leadership-update-6468061)
- 2026-03-25 11:00 UTC [Leadership Update] [Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.](https://www.quantisnow.com/insight/inscobee-inc-and-apimeds-inc-reaffirms-appointment-of-new-board-6468047)
- 2026-03-24 12:30 UTC [Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-announces-material-breach-of-merger-agreement-6466308)
- 2026-03-16 20:30 UTC [SEC Form 8-K] [Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-other-events-6449770)
- 2026-02-17 21:31 UTC [SEC Form 425] [SEC Form 425 filed by Apimeds Pharmaceuticals US Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-apimeds-pharmaceuticals-us-inc-6396569)
- 2026-02-17 21:30 UTC [SEC Form 8-K] [Amendment: Apimeds Pharmaceuticals US Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets](https://www.quantisnow.com/insight/amendment-apimeds-pharmaceuticals-us-inc-filed-sec-form-8-k-financial-6396524)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/APUS
- Earnings history: https://www.quantisnow.com/earnings/APUS
- Dividend history: https://www.quantisnow.com/dividends/APUS
- Insider transactions: https://www.quantisnow.com/insiders/APUS
- Options chain: https://www.quantisnow.com/options/APUS
- SEC 8-K filings only: https://www.quantisnow.com/company/APUS/8-k
- RSS and alerts for APUS: https://www.quantisnow.com/docs/rss-feeds.md